Keywords: |
immunohistochemistry; signal transduction; cancer chemotherapy; cancer survival; protein expression; overall survival; genetics; drug efficacy; drug safety; side effect; note; cancer patient; cancer grading; ovarian neoplasms; biomarkers; biological marker; progression free survival; ovary cancer; tumor marker; cancer hormone therapy; ovary tumor; tamoxifen; receptors, estrogen; letrozole; cystadenocarcinoma, serous; estrogen receptor; progesterone receptor; cystadenocarcinoma; selumetinib; cancer prognosis; trametinib; humans; human; female; binimetinib; biomarkers, tumor
|